Jianmin Pharmaceutical Group Co Ltd (600976) — Cash Flow-to-Debt Ratio
Jianmin Pharmaceutical Group Co Ltd (600976) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of CN¥106.82 Million could theoretically repay 0% of its total liabilities (CN¥1.81 Billion) in one year. Explore Jianmin Pharmaceutical Group Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jianmin Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Jianmin Pharmaceutical Group Co Ltd across 23 annual periods. Also explore Jianmin Pharmaceutical Group Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jianmin Pharmaceutical Group Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Jianmin Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see Jianmin Pharmaceutical Group Co Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥274.53 Million | CN¥1.81 Billion | ▲ +18.6% |
| 2024 | 0.13x | CN¥234.27 Million | CN¥1.83 Billion | ▼ -8.7% |
| 2023 | 0.14x | CN¥268.39 Million | CN¥1.91 Billion | ▲ +2.1% |
| 2022 | 0.14x | CN¥215.87 Million | CN¥1.57 Billion | ▼ -33.3% |
| 2021 | 0.21x | CN¥259.18 Million | CN¥1.26 Billion | ▲ +79.6% |
| 2020 | 0.11x | CN¥125.54 Million | CN¥1.09 Billion | ▲ +11.1% |
| 2019 | 0.10x | CN¥74.45 Million | CN¥720.63 Million | ▼ -6.3% |
| 2018 | 0.11x | CN¥63.60 Million | CN¥577.11 Million | ▲ +155.7% |
| 2017 | 0.04x | CN¥35.20 Million | CN¥816.71 Million | ▼ -70.6% |
| 2016 | 0.15x | CN¥113.84 Million | CN¥776.45 Million | ▲ +83.0% |
| 2015 | 0.08x | CN¥48.45 Million | CN¥604.72 Million | ▼ -57.7% |
| 2014 | 0.19x | CN¥103.23 Million | CN¥544.79 Million | ▲ +110.9% |
| 2013 | 0.09x | CN¥45.36 Million | CN¥504.92 Million | ▼ -67.3% |
| 2012 | 0.27x | CN¥98.17 Million | CN¥357.90 Million | ▲ +205.8% |
| 2011 | -0.26x | CN¥-75.54 Million | CN¥291.28 Million | ▼ -139.5% |
| 2010 | 0.66x | CN¥150.08 Million | CN¥228.78 Million | ▲ +368.0% |
| 2009 | 0.14x | CN¥66.69 Million | CN¥475.79 Million | ▼ -49.4% |
| 2008 | 0.28x | CN¥110.11 Million | CN¥397.80 Million | ▲ +675.4% |
| 2007 | -0.05x | CN¥-6.88 Million | CN¥143.07 Million | ▼ -124.4% |
| 2006 | 0.20x | CN¥56.18 Million | CN¥285.18 Million | ▲ +271.4% |
| 2005 | -0.11x | CN¥-34.63 Million | CN¥301.33 Million | ▼ -710.1% |
| 2004 | 0.02x | CN¥4.13 Million | CN¥219.38 Million | ▲ +9.0% |
| 2003 | 0.02x | CN¥4.19 Million | CN¥242.31 Million | — |